- Home
- DAWN vs RKT Comparison
DAWN vs RKT Comparison
Compare DAWN & RKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- RKT
- Stock Information
- Founded
- DAWN 2018
- RKT 1985
- Country
- DAWN United States
- RKT United States
- Employees
- DAWN N/A
- RKT N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- RKT Finance: Consumer Services
- Sector
- DAWN Health Care
- RKT Finance
- Exchange
- DAWN Nasdaq
- RKT Nasdaq
- Market Cap
- DAWN 1.3B
- RKT 1.5B
- IPO Year
- DAWN 2021
- RKT 2020
- Fundamental
- Price
- DAWN $12.24
- RKT $11.97
- Analyst Decision
- DAWN Strong Buy
- RKT Sell
- Analyst Count
- DAWN 7
- RKT 13
- Target Price
- DAWN $36.33
- RKT $13.81
- AVG Volume (30 Days)
- DAWN 1.1M
- RKT 3.5M
- Earning Date
- DAWN 02-24-2025
- RKT 02-20-2025
- Dividend Yield
- DAWN N/A
- RKT N/A
- EPS Growth
- DAWN N/A
- RKT N/A
- EPS
- DAWN N/A
- RKT N/A
- Revenue
- DAWN $101,953,000.00
- RKT $4,304,653,000.00
- Revenue This Year
- DAWN N/A
- RKT $16.03
- Revenue Next Year
- DAWN $35.22
- RKT $29.17
- P/E Ratio
- DAWN N/A
- RKT N/A
- Revenue Growth
- DAWN N/A
- RKT 13.77
- 52 Week Low
- DAWN $11.13
- RKT $10.06
- 52 Week High
- DAWN $18.07
- RKT $21.38
- Technical
- Relative Strength Index (RSI)
- DAWN 45.74
- RKT 53.52
- Support Level
- DAWN $11.13
- RKT $11.22
- Resistance Level
- DAWN $12.74
- RKT $12.50
- Average True Range (ATR)
- DAWN 0.51
- RKT 0.47
- MACD
- DAWN 0.06
- RKT 0.27
- Stochastic Oscillator
- DAWN 51.15
- RKT 78.28
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About RKT Rocket Companies Inc.
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and is now the largest mortgage originator in the U.S. as well as the servicer for more than 2 million loans.